Live from the NIH registry
Studies recruiting near Hialeah right now
Top 25 of 1,939 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 893 participants sought
University of Miami Hospital and Clinics — Miami, Florida (9.5 mi)
· Sponsor: Pfizer
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Nicklaus Children's Hospital — Miami, Florida (9.5 mi)
· Sponsor: Nationwide Children's Hospital
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida (12.1 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
University of Miami - Miller School of Medicine — Coral Gables, Florida (10.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
University of Miami Miller School of Medicine-Sylvester Cancer Center — Miami, Florida (9.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Mount Sinai Braman Comprehensive Cancer Center ( Site 0140) — Miami Beach, Florida (12.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Direct Helpers Research Center — Hialeah, Florida (1.8 mi)
· Sponsor: Takeda
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Heart Failure (HF)
N/A
Interventional 420 participants sought
Cleveland Clinic Florida — Weston, Florida (17.0 mi)
· Sponsor: Aventusoft, LLC.
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Flourish Research - Miami, LLC dba Flourish Research — Miami, Florida (9.5 mi)
· Sponsor: AbbVie
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Miami, Florida (9.5 mi)
· Sponsor: Sameek Roychowdhury
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Miami Beach, Florida (12.1 mi)
· Sponsor: AstraZeneca
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Skin Care Research, LLC — Hollywood, Florida (13.7 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Ft Lauderdale Eye Institute — Plantation, Florida (18.8 mi)
· Sponsor: Genentech, Inc.
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Miami — Miami, Florida (9.5 mi)
· Sponsor: Jaeb Center for Health Research
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Tamarac, Florida (24.0 mi)
· Sponsor: Daiichi Sankyo
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS)
N/A
Interventional 10 participants sought
Nova Southeastern University, David and Cathy Husman Neuroscience Institute — Davie, Florida (14.1 mi)
· Sponsor: Nova Southeastern University
Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery
Perineal Injury, Pain Vulva
Phase 4
Interventional 70 participants sought
University of Miami Hospitals and Clinics — Miami, Florida (9.5 mi)
· Sponsor: University of Miami
CelluJuve® for the Treatment of Moderate to Severe NLFs
Nasolabial Fold Wrinkles
N/A
Interventional 12 participants sought
Skin Research Institute LLC — Coral Gables, Florida (10.5 mi)
· Sponsor: Spiderwort Biotechnologies Inc.
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 120 participants sought
West Broward Rheumatology Associates, Inc. — Tamarac, Florida (24.0 mi)
· Sponsor: Hoffmann-La Roche
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Advanced Cancer, Solid Tumor
Phase 1
Interventional 26 participants sought
University of Miami — Miami, Florida (9.5 mi)
· Sponsor: Proviva Therapeutics, Inc.
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Nicklaus Children's Hospital — Miami, Florida (9.5 mi)
· Sponsor: Nationwide Children's Hospital
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Felicidad Med Research — Hialeah, Florida (1.8 mi)
· Sponsor: Philip Morris Products S.A.
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Pembroke Pines, Florida (10.5 mi)
· Sponsor: Ambros Therapeutics, Inc.
A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages
Cheek Wrinkles, Menopausal Women
N/A
Interventional 40 participants sought
Miami Dermatology & Laser Institute — Miami, Florida (9.5 mi)
· Sponsor: Galderma R&D
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
L&A Morales Healthcare, Inc — Hialeah, Florida (1.8 mi)
· Sponsor: Acurx Pharmaceuticals Inc.